Nurix Therapeutics, Inc. SEC filings NRIX
Nurix Therapeutics, Inc. has 561 filings in SEC EDGAR's recent list, going back to May 15, 2012. Its latest annual report, Form ARS, was filed on Mar 27, 2026 for the period ended Nov 30, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 13, 2026, covering the quarter ended Aug 31, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (other events). The company's fiscal year ends on November 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 4, 2026 | Nov 4, 2026 |
| 4 | Insider transaction | Nov 4, 2026 | Nov 2, 2026 |
| 144 | Notice of proposed sale | Nov 4, 2026 | — |
| 144 | Notice of proposed sale | Nov 3, 2026 | — |
| 8-K |
Current report
Other events
|
Nov 3, 2026 | Nov 3, 2026 |
| 4 | Insider transaction | Nov 2, 2026 | Oct 30, 2026 |
| 4 | Insider transaction | Nov 2, 2026 | Oct 30, 2026 |
| 4 | Insider transaction | Nov 2, 2026 | Oct 30, 2026 |
| 144 | Notice of proposed sale | Nov 2, 2026 | — |
| 4 | Insider transaction | Oct 15, 2026 | Oct 15, 2026 |
| 144 | Notice of proposed sale | Oct 14, 2026 | — |
| 4 | Insider transaction | Oct 14, 2026 | Oct 14, 2026 |
| 10-Q | Quarterly report | Oct 13, 2026 | Aug 31, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 13, 2026 | Oct 12, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Oct 2, 2026 |
| 144 | Notice of proposed sale | Oct 2, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 23, 2026 | — |
| 4 | Insider transaction | Sep 2, 2026 | Sep 2, 2026 |
| 144 | Notice of proposed sale | Sep 2, 2026 | — |
| 4 | Insider transaction | Sep 1, 2026 | Sep 1, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 4 | Insider transaction | Aug 5, 2026 | Aug 5, 2026 |
| 144 | Notice of proposed sale | Aug 5, 2026 | — |
| 4 | Insider transaction | Aug 5, 2026 | Aug 4, 2026 |
| 4 | Insider transaction | Aug 4, 2026 | Aug 4, 2026 |
| 144 | Notice of proposed sale | Aug 4, 2026 | — |
| 144 | Notice of proposed sale | Aug 4, 2026 | — |
| 4 | Insider transaction | Aug 3, 2026 | Aug 3, 2026 |
| 144 | Notice of proposed sale | Aug 3, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 31, 2026 | — |
| 4 | Insider transaction | Jul 30, 2026 | Jul 30, 2026 |
| 4 | Insider transaction | Jul 30, 2026 | Jul 30, 2026 |
| 4 | Insider transaction | Jul 30, 2026 | Jul 30, 2026 |
| 10-Q | Quarterly report | Jul 9, 2026 | May 31, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 9, 2026 | Jul 9, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jul 2, 2026 |
| 144 | Notice of proposed sale | Jul 2, 2026 | — |
| 4 | Insider transaction | Jun 25, 2026 | Jun 25, 2026 |
| 4 | Insider transaction | Jun 25, 2026 | Jun 25, 2026 |
| 144 | Notice of proposed sale | Jun 25, 2026 | — |
| 144 | Notice of proposed sale | Jun 25, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 11, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 8, 2026 | Jun 6, 2026 |
| 4 | Insider transaction | Jun 2, 2026 | Jun 2, 2026 |
| 144 | Notice of proposed sale | Jun 2, 2026 | — |
| 4 | Insider transaction | May 15, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 15, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 15, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 15, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 15, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 15, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 15, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 15, 2026 | May 15, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
May 15, 2026 | May 15, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 6, 2026 | — |
| 4 | Insider transaction | May 5, 2026 | May 5, 2026 |
| 144 | Notice of proposed sale | May 5, 2026 | — |
| 4 | Insider transaction | May 4, 2026 | May 4, 2026 |
| 144 | Notice of proposed sale | May 4, 2026 | — |
| 4 | Insider transaction | May 1, 2026 | May 1, 2026 |
| 144 | Notice of proposed sale | May 1, 2026 | — |
| 4 | Insider transaction | Apr 30, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | Apr 30, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | Apr 30, 2026 | Apr 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 24, 2026 | — |
| 10-Q | Quarterly report | Apr 8, 2026 | Feb 28, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 8, 2026 | Apr 8, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Apr 2, 2026 |
| 144 | Notice of proposed sale | Apr 2, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 27, 2026 | — |
| ARS | Annual report to shareholders | Mar 27, 2026 | Nov 30, 2025 |
| DEFA14A | Additional proxy material | Mar 27, 2026 | — |
| DEF 14A | Proxy statement | Mar 27, 2026 | May 15, 2026 |
| 8-K |
Current report
Other events
|
Mar 6, 2026 | Mar 6, 2026 |
| 424B5 | Prospectus supplement | Mar 6, 2026 | — |
| 4 | Insider transaction | Mar 2, 2026 | Mar 2, 2026 |
| 144 | Notice of proposed sale | Mar 2, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| 4 | Insider transaction | Feb 10, 2026 | Feb 10, 2026 |
| 4 | Insider transaction | Feb 10, 2026 | Feb 10, 2026 |
| 4 | Insider transaction | Feb 10, 2026 | Feb 10, 2026 |
| 4 | Insider transaction | Feb 10, 2026 | Feb 10, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 9, 2026 |
| 144 | Notice of proposed sale | Feb 9, 2026 | — |
| 4 | Insider transaction | Feb 3, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Jan 30, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Jan 30, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Jan 30, 2026 | Jan 30, 2026 |
| S-8 | Employee stock plan registration | Jan 28, 2026 | — |
| 10-K | Annual report | Jan 28, 2026 | Nov 30, 2025 |
| 8-K |
Current report
Results of operations
|
Jan 28, 2026 | Jan 28, 2026 |
| 4 | Insider transaction | Jan 20, 2026 | Jan 20, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 18, 2025 |
| 144 | Notice of proposed sale | Dec 18, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 9, 2025 | Dec 6, 2025 |
| 4 | Insider transaction | Nov 24, 2025 | Nov 24, 2025 |
| 144 | Notice of proposed sale | Nov 24, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 4 | Insider transaction | Nov 10, 2025 | Nov 6, 2025 |
| 3 | Initial insider ownership | Nov 10, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Officer or director change
|
Nov 10, 2025 | Nov 6, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 7, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 5, 2025 | — |
| 4 | Insider transaction | Nov 3, 2025 | Nov 3, 2025 |
| 144 | Notice of proposed sale | Nov 3, 2025 | — |
| 4 | Insider transaction | Oct 30, 2025 | Oct 30, 2025 |
| 4 | Insider transaction | Oct 30, 2025 | Oct 30, 2025 |
| 4 | Insider transaction | Oct 30, 2025 | Oct 30, 2025 |
| 4 | Insider transaction | Oct 23, 2025 | Oct 14, 2025 |
| 424B5 | Prospectus supplement | Oct 22, 2025 | — |
| 8-K |
Current report
Other events
|
Oct 22, 2025 | Oct 22, 2025 |
| FWP | Free writing prospectus | Oct 22, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 22, 2025 | Oct 22, 2025 |
| 10-Q | Quarterly report | Oct 9, 2025 | Aug 31, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 9, 2025 | Oct 9, 2025 |
| 4 | Insider transaction | Sep 17, 2025 | Sep 17, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 3, 2025 | Sep 3, 2025 |
| 8-K |
Current report
Officer or director change
|
Aug 22, 2025 | Aug 19, 2025 |
| 4 | Insider transaction | Aug 1, 2025 | Aug 1, 2025 |
| 144 | Notice of proposed sale | Aug 1, 2025 | — |
| 4 | Insider transaction | Jul 30, 2025 | Jul 30, 2025 |
| 4 | Insider transaction | Jul 30, 2025 | Jul 30, 2025 |
| 4 | Insider transaction | Jul 30, 2025 | Jul 30, 2025 |
| 10-Q | Quarterly report | Jul 9, 2025 | May 31, 2025 |
| 8-K |
Current report
Results of operations
|
Jul 9, 2025 | Jul 9, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 12, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | May 19, 2025 | May 19, 2025 |
| 4 | Insider transaction | May 19, 2025 | May 19, 2025 |
| 4 | Insider transaction | May 19, 2025 | May 19, 2025 |
| 4 | Insider transaction | May 19, 2025 | May 19, 2025 |
| 4 | Insider transaction | May 19, 2025 | May 19, 2025 |
| 4 | Insider transaction | May 19, 2025 | May 19, 2025 |
| 4 | Insider transaction | May 19, 2025 | May 19, 2025 |
| 4 | Insider transaction | May 19, 2025 | May 19, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 19, 2025 | May 19, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2025 | — |
| 4 | Insider transaction | May 2, 2025 | May 2, 2025 |
| 144 | Notice of proposed sale | May 2, 2025 | — |
| 4 | Insider transaction | Apr 30, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | Apr 30, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | Apr 30, 2025 | Apr 30, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 23, 2025 | — |
| 10-Q | Quarterly report | Apr 8, 2025 | Feb 28, 2025 |
| 8-K |
Current report
Results of operations
|
Apr 8, 2025 | Apr 8, 2025 |
| DEFA14A | Additional proxy material | Mar 28, 2025 | — |
| ARS | Annual report to shareholders | Mar 28, 2025 | Nov 30, 2024 |
| DEF 14A | Proxy statement | Mar 28, 2025 | May 19, 2025 |
| UPLOAD | Letter from the SEC | Mar 19, 2025 | — |
| CORRESP | Letter to the SEC | Mar 13, 2025 | — |
| 4 | Insider transaction | Mar 13, 2025 | Mar 11, 2025 |
| 3 | Initial insider ownership | Mar 13, 2025 | Mar 11, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 13, 2025 | Mar 11, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Mar 3, 2025 |
| 144 | Notice of proposed sale | Mar 3, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 28, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 4 | Insider transaction | Feb 13, 2025 | Feb 11, 2025 |
| 4 | Insider transaction | Feb 13, 2025 | Feb 11, 2025 |
| 4 | Insider transaction | Feb 13, 2025 | Feb 11, 2025 |
| 4 | Insider transaction | Feb 13, 2025 | Feb 11, 2025 |
| 4 | Insider transaction | Feb 3, 2025 | Jan 31, 2025 |
| 144 | Notice of proposed sale | Jan 31, 2025 | — |
| 4 | Insider transaction | Jan 30, 2025 | Jan 30, 2025 |
| 4 | Insider transaction | Jan 30, 2025 | Jan 30, 2025 |
| 4 | Insider transaction | Jan 30, 2025 | Jan 30, 2025 |
| S-8 | Employee stock plan registration | Jan 28, 2025 | — |
| 10-K | Annual report | Jan 28, 2025 | Nov 30, 2024 |
| 8-K |
Current report
Results of operations
|
Jan 28, 2025 | Jan 28, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 10, 2025 | — |
| 4 | Insider transaction | Jan 2, 2025 | Jan 2, 2025 |
| 144 | Notice of proposed sale | Jan 2, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 10, 2024 | Dec 9, 2024 |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 6, 2024 | — |
| 4 | Insider transaction | Dec 2, 2024 | Dec 2, 2024 |
| 144 | Notice of proposed sale | Dec 2, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 7, 2024 | — |
| 4 | Insider transaction | Nov 4, 2024 | Nov 4, 2024 |
| 144 | Notice of proposed sale | Nov 4, 2024 | — |
| 4 | Insider transaction | Nov 1, 2024 | Nov 1, 2024 |
| 4 | Insider transaction | Nov 1, 2024 | Nov 1, 2024 |
| 144 | Notice of proposed sale | Nov 1, 2024 | — |
| 144 | Notice of proposed sale | Nov 1, 2024 | — |
| 424B5 | Prospectus supplement | Oct 31, 2024 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NRIX (Nasdaq)
- Fiscal year ends
- November 30
- Incorporated in
- DE
- Headquarters
- Brisbane, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1549595
- Former names
- Nurix, Inc. (until Sep 18, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.